Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Random forest classification for predicting lifespan-extending chemical compounds

Abstract

Ageing is a major risk factor for many conditions including cancer, cardiovascular and neurodegenerative diseases. Pharmaceutical interventions that slow down ageing and delay the onset of age-related diseases are a growing research area. The aim of this study was to build a machine learning model based on the data of the DrugAge database to predict whether a chemical compound will extend the lifespan of Caenorhabditis elegans. Five predictive models were built using the random forest algorithm with molecular fingerprints and/or molecular descriptors as features. The best performing classifier, built using molecular descriptors, achieved an area under the curve score (AUC) of 0.815 for classifying the compounds in the test set. The features of the model were ranked using the Gini importance measure of the random forest algorithm. The top 30 features included descriptors related to atom and bond counts, topological and partial charge properties. The model was applied to predict the class of compounds in an external database, consisting of 1738 small-molecules. The chemical compounds of the screening database with a predictive probability of ≥ 0.80 for increasing the lifespan of Caenorhabditis elegans were broadly separated into (1) flavonoids, (2) fatty acids and conjugates, and (3) organooxygen compounds.

Introduction

Pharmacological interventions for longevity extension

Ageing is a major health, social and financial challenge, characterised by the deterioration of the physiological processes of an organism1,2. Ageing is a predominant risk factor for many conditions including various types of cancers, cardiovascular and neurodegenerative diseases3,4. Interventions targeting the cellular and molecular process of ageing have the potential to delay and protect against age-related conditions.

Several ageing studies have identified interventions that extend the lifespan of model organisms ranging from nematodes and fruit flies to rodents, using dietary restrictions, genetic modifications and pharmaceutical interventions. Lee et al. (2006) presented the first evidence that long-term dietary deprivation can improve longevity in a multicellular species, Caenorhabditis elegans (C. elegans)5. A few years later, Harrison et al. (2009) found that treating mice with rapamycin, an inhibitor of the mTOR pathway, extended the median and maxim lifespan of the mice6. Additionally, Selman et al. (2009) reported that genetic deletion of S6 protein kinase 1, a component of the mTOR signalling pathway, increased the lifespan of mice and protected against age-related conditions7.

Ye et al. (2014) developed a pharmacological network to identify pharmacological classes related to the ageing of C. elegans8. The network showed that resistance to oxidative stress and lifespan extension clustered in a few pharmacological classes, most of them related to intercellular signalling8. Moreover, Putin et al. (2016) developed a deep learning neural network that predicted human chronological age from a basic blood test9. The study identified the top five most critical blood markers for determining chronological age in humans, which were albumin, glucose, alkaline phosphatase, urea and erythrocytes9. Additionally, Mamoshina et al. (2018) developed a deep learning-based haematological ageing clock using blood samples from Canadian, South Korean, and Eastern European populations, with millions of subjects10. The findings showed that population-specific ageing clocks were more accurate in predicting chronological age and quantifying biological age than generic ageing clocks10.

Barardo et al. (2017) built a random forest model to predict whether a compound would increase the lifespan of C. elegans based on the data of the DrugAge database1,4. The features used to build the model were molecular descriptors and gene ontology terms. Feature selection was performed using random forest’s feature importance measure. The best performing model, with an AUC score of 0.80, was applied to predict the class of the compounds in the DGIdb database.

Purpose of the work

This study builds on the work conducted by Barardo et al. (2017) to further explore the use of the DrugAge database for predicting compounds with anti-ageing properties4. Specifically, the random forest algorithm was employed to predict whether a compound will increase the lifespan of C. elegans. This was achieved by building five predictive models, each using different descriptor types, based on the data of the DrugAge database published by Barardo et al. (2017)4. The features of the models were molecular fingerprints and/or molecular descriptors calculated from the structure of the compounds in the DrugAge database. Feature selection was performed using variance and mutual information-based methods. To the best of our knowledge, this is the first implementation of molecular fingerprints for building machine learning models based on the entries of the DrugAge database. The best performing model was applied to predict the class of the compounds in an external database, consisting of 1738 small-molecules extracted from the DrugBank database11.

Random forest models

Random forest is a supervised machine learning technique, consisted of an ensemble of decision trees, where each tree is trained independently using a random subset of the data12. The random forest model is widely used in chemo- and bioinformatics related tasks as it is robust to overfitting on high dimensional databases with a small sample sizes4.

The choice of chemical descriptors can significantly impact the quality and predictions of quantitative structure–activity relationship (QSAR) models. Descriptors represent chemical information of molecules in a digital or numerical way that is suitable for model development and are computer-interpretable13,14. In this study, 2D and 3D molecular descriptors were calculated using the Molecular Operating Environment (MOE) software15. 2D descriptors are calculated from the 2D structure of a molecule and provide information related to its structural, topological and physicochemical properties16. On the other hand, 3D descriptors are generated from the 3D structure of a chemical compound and include electronic parameters (e.g. dipole momentum), quantum–chemical descriptors (e.g. HOMO and LUMO energies), and surface:volume descriptors14,17,18.

Molecular fingerprints represent the molecule’s structure using binary vectors, where 1 corresponds to a particular feature or structural group being present and 0 that it is absent. Herein, extended-connectivity fingerprints (ECFP) of 1024- and 2048-bit lengths and RDKit topological fingerprints of 2048-bit length were generated in the RDKit Python environment19. Lastly, the combination of molecular descriptors with ECFPs was tested.

Results and discussion

Feature selection

Variance and mutual information filter-based methods were employed to select a subset of relevant features for predicting the anti-ageing properties of the molecules in the dataset. This was performed only for the training set which contained 80% of compounds in the dataset. Feature selection reduced the number of variables used by each model, making computational calculations less expensive. The median AUC scores and standard deviation of tenfold cross-validation (on the training set) obtained by random forest classification for each feature subset can be found in Supplementary Fig. 1, Additional File 1. The feature subset with the highest AUC score in 10-fold cross-validation was selected for classifying the compounds in the test set. In cases where two feature subsets achieved the same AUC score, the subset with the lowest standard deviation was used.

Model selection

The test set contained 20% of the data not used in training the models. The performances of the random forest classifiers on the test and train set as well as the optimal number of variables obtained by feature selection are shown in Table 1.

Table 1 Performances on tenfold cross-validation and the test set achieved by each descriptor type; ECFP (1024-bit length), ECFP (2048-bit length), RDKit fingerprints (2048-bit length), molecular descriptors and the combination of ECFP (1024-bit length) with molecular descriptors.

As illustrated in Fig. 1, the predictive performances of the random forest models built with ECFP and MD features did not significantly drop for classifying the compounds in the test set and were compatible with the spread of the AUC scores from cross-validation. This indicated that overfitting was minimised. On the other hand, the performance of the classifier using topological RDKit fingerprints on the test set dropped by approximately 6%. Therefore, the RDKit5 model was not selected for predicting the effect of the compounds in the screening database on the lifespan of C. elegans.

Figure 1
figure 1

Box-and-whisker plot displaying the distribution of the AUC for the tenfold cross-validation (CV) on the training set and the AUC score for the single measurement taken on the test set, obtained by random forest classification. Each box represents the cross-validation data for a different model, where ECFP of 1024-bit length is shown in green, ECFP of 2048-bit length in blue, RDKit fingerprints in pink, molecular descriptors in red and the combination of ECFP of 1024-bit length with molecular descriptors are represented in orange colour. The value reported within the boxes is the median AUC value of the tenfold cross-validation. The points outside the boxplots represent possible outliers.

The receiver operating characteristic (ROC) curve is the plot of the True Positive Rate (TPR) against the False Positive Rate (FPR) at varying classification thresholds. The ROC curves, displayed in Fig. 2, compare the performances of the descriptor types for classifying the samples of the test set. The figure illustrates that the five random forest models performed better than a random prediction.

Figure 2
figure 2

The ROC curves comparing the performances of the ECFP_1024 (in grey), ECFP_2048 (in green), RDKit5 (in orange), MD (in purple) and ECFP_1024_MD (in blue) for classifying the compounds in the test set. The AUC scores are reported for each descriptor type. The red dashed line corresponds to a random classifier, that gives random answers, with an AUC value of 0.520.

The best performing model, selected by its ability to correctly classify the compounds in the test set, was used for predicting the class of the compounds in the screening dataset. The classifier built solely with molecular descriptors (MD), achieved the highest AUC score for predicting the class of the compounds in the test set. Combining MD with ECFP_1024, the feature type used to obtain the model with the second-highest predictive ability, did not further improve the performance of the classifier. The ECFP_1024 features could have provided additional information that was not useful to the random forest classifier making the predictions more difficult. Therefore, the MD model, which had an AUC score of 0.815 for classifying the compounds in the test set, was selected for further analysis.

Confusion matrix

The confusion matrix of the MD model for predicting the class of the molecules in the test set is shown in Fig. 3. The classification accuracy of the model was 0.853 and the AUC score was 0.815.

Figure 3
figure 3

The confusion matrix was obtained from the performance of the MD model on the test set. The test set had a total of 286 compounds, of which 52 were active and 234 were inactive.

The calculation of the Positive Predictive Value (PPV), Equation, and Negative Predictive Value (NPV), Equation, is shown below:

$$\begin{aligned} {\text{PPV}} & = {\text{~}}\frac{{{\text{True~}}\;{\text{Positives}}}}{{{\text{True}}\;{\text{~Positives}} + {\text{False}}\;{\text{~Positives}}}} \\ {\text{PPV}} & = ~\frac{{21}}{{21 + 11~}} = 65.6~\% \\ \end{aligned}$$
(1)
$$\begin{aligned} {\text{NPV}} & = ~\frac{{{\text{True}}\;{\text{~Negatives}}}}{{{\text{True}}\;{\text{~Negatives}} + {\text{False}}\;{\text{~Negatives}}}} \\ {\text{NPV}} & = ~\frac{{223}}{{223 + 31~}} = 87.8~\% \\ \end{aligned}$$
(2)

In binary classification, the PPV and NPV are the percentage of correctly classified compounds among all compounds predicted as positives or negatives, respectively. Herein, the PPV and NPV indicate that the random forest model performed better on correctly classifying inactive compounds than active ones. The data used in this study was imbalanced as approximately 79% of the samples were negative entries. Thus, a random prediction that a compound is inactive had a much higher initial probability of being correct. To handle the imbalanced data, the “class_weight” argument of the random forest algorithm was set to “balanced”, which penalises misclassification of the minority class (i.e. the positive samples)21. The remaining parameters of the random forest model were left to the default settings of the scikit-learn Python library (please refer to the “Random forest settings” section in the Methods)22. This increased the PPV for classifying the compounds in the test set from 61.1% (value without balancing the class weights) to 65.6% (score achieved after balancing the class weights), while the NPV was reduced by 0.2%.

Feature importance

Investigating which features are considered “more important” by black-box models such as random forest can aid understanding of how these models make predictions. In this experiment, the feature relevance was measured using the “Gini importance” of the random forest algorithm. The selected model, MD, was composed of 69 molecular descriptors calculated by the MOE software23. The table containing the full feature ranking can be found in Additional File 2. The analysis was focused on the top 30 features with the highest Gini importance (Table 2), which contained both 2D and 3D molecular descriptors.

Table 2 Top 30 features ranked by Gini importance for the MD random forest model. The description of the features was taken from the MOE software documentation23.

The highest-ranking features were broadly separated into the following categories (1) atom and bond counts (2) topological and (3) partial charge descriptors.

Atom and bond counts are simple descriptors that do not provide any information on molecular geometry or atom connectivity. The highest-ranking atom and bond count descriptors were a_nN, b_single, a_count, opr_brigid, and a_nH. While very simplistic, the atom and bond counts outperformed more complex 2D and 3D molecular descriptors. This is because atom and bond counts can partially capture the overall properties of a compound such as size, hydrogen bonding and polarity, which often impact the activity of a drug24. The number of nitrogen atoms, a_nN, was the top-ranking feature of the MD random forest model with a Gini importance score of 0.062. This is consistent with the results of Barardo et al. (2017) where a_nN was also ranked highest for predicting the class of the compounds in the DrugAge database4. Nitrogen atoms could have affected the physicochemical properties of the drugs as well as the interactions and binding of the molecules with target residues.

The highest-ranking topological descriptors included chi0_C, chi0v_C, zagreb, weinerPol, Kier3, chi0 and Kier2. Topological descriptors take into account atom connectivity. The descriptors are computed from molecular graphs, where atoms are represented by vertices and the bonds by edges25. These descriptors can provide information on the degree branching of the structure as well as molecular size and shape25. Although topological descriptors are extensively used in predictive modelling, they are usually hard to interpret26. Topological descriptors may have provided information on how well a molecule fits in the binding site and along with atom counts the interactions with the binding residues.

Top ranking partial charge descriptors were PEOE_VSA + 2, PEOE_VSA-4, PEOE_VSA + 4, PEOE_VSA-6, PEOE_VSA_PPOS, Q_VSA_PNEG, PEOE_VSA_POL, Q_VSA_PPOS and PEOE_VSA_PNEG. The “PEOE_” prefix denotes descriptors calculated using the partial equalization of orbital electronegativity (PEOE) algorithm for quantification of partial charges in the \(\sigma\)-system27,28. On the other hand, descriptors prefixed with “Q_” were calculated using the Amber10:EHT force field23. In a ligand-receptor system, partial charges can play a key role in the binding properties of the molecule as well as molecular recognition.

Predicting potential lifespan-extending compounds

The MD random forest model was applied to predict the class compounds in an external database, consisting of 1738 small-molecules obtained from the DrugBank database11. The top-ranking compounds with a predictive probability of \(\ge 0.80\) for increasing the lifespan of C. elegans are shown in Table 3. The full ranking of the molecules in the screening database can be found in Additional File 2. The compounds were broadly separated into the following categories; (1) flavonoids, (2) fatty acids and conjugates, and (3) organooxygen compounds. The compounds were classified based on categories “Class” and “Sub Class” of the chemical taxonomy section of the DrugBank database (provided by Classyfire) or assigned manually if not present29.

Table 3 Chemical compounds from the screening database with a predictive probability of 0.80 or above for increasing the of C. elegans.

Flavonoids

Flavonoids are a group of secondary metabolites in plants that are common polyphenols in the human diet30. Major nutritional sources include tea, soy, fruits, vegetables, wine and nuts30,31. Flavonoids are separated into subclasses based on their chemical structure, including flavones, flavonols, flavanones, and isoflavones30.

Flavonoids have been associated with health benefits for age-related conditions such as metabolic diseases, cancer, inflammation and cognitive decline30,31. Possible mechanisms of action include antioxidant activity, scavenging of radicals, central nervous system effects, alteration of the intestinal transport, sequestration and processing of fatty acids, PPAR activation and increase of insulin sensitivity30.

Diosmin was the top-hit molecule in the screening database, with a predictive probability of 0.96. Diosmin is a flavonol glycoside that is either extracted from plants such as Rutaceae or obtained synthetically32. It has anti-inflammatory, free radical scavenging, and anti-mutagenic properties and has been used medically to treat pain and bleeding of haemorrhoids, chronic venous disease and lymphedema33. Nevertheless, diosmin has poor aqueous solubility, which is a challenge for oral administration34. Kamel et al. (2017) found that a combination of diosmin with essential oils showed skin antioxidant, anti-ageing and sun-blocking effects on mice34. The underlying mechanisms for diosmin’s anti-ageing and photo-protective effects include enhancing lymphatic drainage, ameliorating capillary microcirculation inflammation and preventing leukocyte activation, trapping, and migration34,35.

Other flavonoids that ranked high for increasing the lifespan of C. elegans were rutin and hesperidin with a predictive probability of 0.95 and 0.94, respectively. Rutin (or quercetin-3-rutinoside), is a flavonol glycoside that is abundant in many plants such as passionflower, apple, tea, buckwheat seeds and citrus fruits36,37. It possesses a range of biological properties including antioxidant, anticancer, neuroprotective, cardio-protective and skin-regenerative activities36,37. Rutin had a high structural similarity to other flavonoids in the DrugAge database and particularly with quercetin 3-O-β-d-glucopyranoside-(4 → 1)-β-d-glucopyranoside (Q3M). The Tanimoto coefficient between the RDKit fingerprints of Q3M and rutin was 0.99. The similarity map between the two compounds is shown in Fig. 4.

Figure 4
figure 4

Similarity map for ECFP fingerprint with a default radius of 2 (a) structure of reference molecule Q3M from the DrugAge database (b) similarity map of rutin. In green colour are bits that if removed will decrease the similarity, whereas removing bits represented in pink colour will increase the similarity between the two compounds38. The figure was created in the RDKit Python environment19.

Q3M is a flavonoid abundant in onion peel that was found to extend the lifespan of C. elegans39. In the same study, even although rutin was found to improve the tolerance of C. elegans to oxidative stress, which is desirable for longevity, rutin (20 μg/mL) did not significantly affect the worm's lifespan39. On the other hand, a more recent study by Cordeiro et al. (2020) found that treatment of C. elegans with 15, 30 and 120 μM rutin increased the lifespan of the nematodes from 28 (control) to 30 days40.

Hesperidin has shown reactive oxygen species (ROS) inhibition and anti-ageing effects in the yeast species Saccharomyces cerevisiae41. Fernández-Bedmar et al. (2011) found that hesperidin extracted from orange juice had a positive influence on the lifespan of D. melanogaster42. Wang et al. (2020) showed that orange extracts, where hesperidin was the predominant phenolic compound, increased the mean lifespan of C. elegans43. In the same study, orange extracts were also found to promote longevity by enhancing motility and reducing the accumulation of age pigment and ROS levels43.

Soy isoflavones include genistein, glycitein, and daidzein. Genistein, a compound of the DrugAge, has been found to prolong the lifespan of C. elegans and increase its tolerance to oxidative stress44. Gutierrez-Zepeda et al. (2005) found that C. elegans fed with soy isoflavone glycitein had an improved resistance towards oxidative stress45. However, in comparison to control worms, the lifespan of C. elegans fed with glycitein (100 μg/ml) was not significantly affected45. The effect of daidzein (100 μM) on the lifespan of C. elegans in the presence of pathogenic bacteria was investigated by Fischer et al. (2012)46. The study found that daidzein had an estrogenic effect that extended the lifespan of the nematode in presence of pathogenic bacteria and heat46. Herein, we applied the MD random forest model to predict the effect of 6''-O-malonyldaidzin on the lifespan of C. elegans. 6''-O-Malonyldaidzin is an o-glycoside derivative of daidzein found in food products such as soybean, miso, soy milk and soy yoghurt47. Its predicted probability for extending the lifespan of the worm was 0.84.

Fatty acids and conjugates

Lipid metabolism has an essential role in many biological processes of an organism. Lipids are used as energy storage in the form of triglycerides and can therefore aid survival under severe conditions48. Additionally, lipids have a key role in intercellular and intracellular signalling as well as organelle homeostasis49. Research on both invertebrates and mammals indicates that alterations in lipid levels and composition are associated with ageing and longevity48,49.

A recent review by Johnson and Stolzing (2019), on lipid metabolism and its role in ageing, summarised key lipid-related interventions that promote longevity in C. elegans50. Some of the studies presented in the review are reported here. O’Rourke et al. (2013), showed that supplementing C. elegans with the \(\omega\)-6 polyunsaturated fatty acids (PUFAs) arachidonic acid and di‐homo‐γ‐linoleic acid (DGLA) increased the worm’s starvation resistance and prolonged its lifespan by stimulating autophagy51. Similarly, Shemesh et al. (2017) found that DGLA extended the lifespan of C. elegans and maintained protein homeostasis in adulthood52. Additionally, Qi et al. (2017), found that treating C. elegans with \(\omega\)-3 PUFA \(\alpha\)-linolenic acid extended the nematodes lifespan53. The study indicated that the \(\omega\)-3 fatty acid underwent oxidation to generate a group of molecules known as oxylipins. The findings suggested that the increase of the worm’s lifespan could be a result of the combined effects of the α-linolenic acid and oxylipin metabolites53. Sugawara et al. (2013) found that a low dose of fish oils, which contained PUFAs eicosapentaenoic acid and docosahexaenoic acid, significantly increased the lifespan of C. elegans54. The authors proposed that a low dose of fish oils induces moderate oxidative stress that extended the lifespan of the organism. In contrast, large amounts of fish oils had a diminishing effect on the worm’s lifespan54.

Gamolenic acid or \(~\gamma\)-linolenic acid (GLA) was the second top-hit molecule of the screening database with a predictive probability of 0.95. GLA is an \(\omega\)-6 PUFA, composed of an 18-carbon chain with three double bonds in the 6th, 9th and 12th position55. Rich sources of GLA include evening primrose oil (EPO), black currant oil, and borage oil56. In mammals, GLA is synthesized from linoleic acid (dietary) via the action of the enzyme \(\delta\)-6 desaturase55,56. GLA is a precursor for other essential fatty acids such as arachidonic acid55,56. Conditions such as hypertension and diabetes as well as stress and various aspects of ageing, reduce the capacity of \(\delta\)-6 desaturase to convert linoleic acid to GLA57. This may lead to a deficiency of long-chain fatty acid derivatives and metabolites of GLA. GLA has been used as a constituent of anti-ageing supplements and has shown to possess various therapeutic effects in humans including improvement of age-related anomalies55.

Sodium aurothiomalate, with a lifespan increase probability of 0.82, is a thia short-chain fatty acid used for the treatment of rheumatoid arthritis and has potential antineoplastic activities29,58. In preclinical models, sodium aurothiomalate inhibited protein kinase C iota (PKCι) signalling, which is overexpressed in non-small cell lung, ovarian and pancreatic cancers58.

Organooxygen compounds

Lactose, with a lifespan increase probability of 0.89, is a disaccharide found in milk and other dairy product. In the human intestine, lactose is hydrolysed to glucose and galactose by the enzyme lactase. Out of the compounds in the DrugAge database, lactose had the highest structural similarity with trehalose. Trehalose has been found to increase the mean lifespan of C. elegans by over 30%, without showing any side effects59. The Tanimoto coefficient between the RDKit fingerprint representations of trehalose and lactose was 0.85. Even though lactose has a high (Tanimoto) similarity to trehalose, Xing et al. (2019) found that lactose treatment at 10, 25, 50 and 100 mM concentrations shortened the lifespan of C. elegans60.

Sucrose, with a lifespan increase probability of 0.83, is a disaccharide composed of glucose and fructose61. It is used as the main form of transporting carbohydrates in fruits and vegetables61. Other sugars such as trehalose, galactose and fructose have been found to extend the lifespan of C. elegans59,62,63. Zheng et al. (2017) found the treating C. elegans with sucrose (55 μM, 111 μM, or 555 μM) had no significant effect on the organism’s mean lifespan63. On the other hand, a more recent study by Wang et al. (2020) found that treatment with 50 μM sucrose significantly increased the lifespan of the nematodes, while a concentration of 400 μM significantly shortened their lifespan64.

Lactulose, with a lifespan increase probability of 0.83, is a synthetic disaccharide composed of monosaccharides lactose and galactose65. Lactulose has shown to be an effective treatment for chronic constipation in elderly patients as well as improve the cognitive function in patients with hepatic encephalopathy65,66.

Other classes of compounds

Other compounds with a predictive probability of ≥ 0.80 for increasing the lifespan of C. elegans included alloin, a constituent of aloe vera with a predictive probability of 0.81, as well as the antibiotics fidaxomicin (predictive probability = 0.84), rifapentine (predictive probability = 0.81) and chlortetracycline (predictive probability = 0.80).

Rifapentine is a macrolactam antibiotic approved for the treatment of tuberculosis67. Macrolactams are a small class of compounds that consist of cyclic amides having unsaturation or heteroatoms replacing one or more carbon atoms in the ring29. Other macrolactams such as rifampicin and rifamycin have been found to increase the lifespan of C. elegans68.

Golegaonkar et al. (2015) showed that rifampicin reduced AGE products and extended the mean lifespan of C. elegans by 60%68. Advanced glycation end (AGE) products are formed from the non-enzymatic reaction of sugars, such as glucose, with proteins, lipids or nucleic acids68. AGE products have been implicated in ageing and age-related diseases such as diabetes, atherosclerosis, and neurodegenerative diseases68. The effect of two other macrolactams, rifamycin SV and rifaximin, on the lifespan of the nematode was also investigated. Rifamycin SV was found to exhibit similar activity to rifampicin, while rifaximin lacked anti-glycating activity and did not extend the lifespan of C. elegans. The authors suggested that the anti-glycation properties of rifampicin and rifamycin could be attributed to the presence of a para-dihydroxyl moiety, which was not present in rifaximin68. As shown in Fig. 5, this functional group is also present in rifapentine. Experimental testing would be required to investigate whether rifapentine possesses similar properties to rifampicin and rifamycin.

Figure 5
figure 5

Chemical structure of (a) rifamycin SV (b) rifampicin (c) rifaximin and (d) rifapentine. The para-dihydroxynaphthyl moiety possessed by rifamycin SV, rifampicin and rifapentine is highlighted in blue. Rifaximin possesses a para-aminophenyl moiety incorporated in a ring system, highlighted in red68. The figure was designed in ChemDraw and redrawn from Golegaonkar et al. (2015)68.

Conclusions

Pharmaceutical interventions that modulate ageing-related genes and pathways are considered the most effective approach for combating human ageing and age-related diseases. Widely used strategies for identifying active compounds include screening existing drugs with potential anti-ageing properties.

In this study, the random forest algorithm was built to predict whether a compound would increase the lifespan of C. elegans using the entries of the DrugAge database, which contains molecules with known anti-ageing properties such as metformin, spermidine, bacitracin, and taxifolin. Our results provide an update on the findings of Barardo et al. (2017), by employing the latest version of the DrugAge database, which includes many more entries. Specifically, five random forest models were built using molecular fingerprints and/or molecular descriptors as features. Feature selection and dimensionality reduction were performed using variation and mutual information-based pre-selection methods. The best performing classifier, the MD model, was built using molecular descriptors and achieved an AUC score of 0.815 for classifying the compounds in the test set. Combining molecular descriptors with ECFPs did not further improve the model’s performance. The features of the MD model were ranked using random forest’s Gini importance measure. Among the 30 highest important features were molecular descriptors related to atom and bond counts, topological and partial charge properties.

The highest performing model was applied to predict the class of the compounds in the screening database which consisted of 1738 small-molecules from DrugBank. The compounds with a predictive probability of ≥ 0.80 for increasing the lifespan of C. elegans were broadly separated into (1) flavonoids, (2) fatty acids and conjugates, and (3) organooxygen compounds.

This study elucidated several molecules such as orange extracts, rutin, lactose and sucrose, that have been experimentally evaluated on C. elegans but were not entries of the predictive database. A limitation of our algorithm is that it does not consider the substance’s dose. For example, at certain concentrations sugars such as sucrose can promote longevity in C. elegans, whereas at higher concentrations such sugars have a detrimental effect on the lifespan of the nematodes64. Moreover, lactose, which received a predictive probability of 0.89 for increasing the lifespan of C. elegans by our model, was found to reduce the lifespan of C. elegans at 10–100 mM concentrations by Xing et al. (2019)60. Nevertheless, the compound could have a beneficial health effect at a different concentration.

Future work would involve in vivo testing of promising compounds such as \(\gamma\)–linolenic acid, rutin, lactulose and rifapentine to investigate their effect on the lifespan of C. elegans, as well as, reevaluate the effect of lactose at lower concentrations. Finally, further work would also explore how the predicted probability of lifespan increase is affected when testing two structurally similar compounds that promote longevity at different concentrations.

Methods

Dataset for predicting lifespan-extending compounds

The dataset published in the study by Barardo et al. (2017) contains positive entries, which are compounds that “increase the lifespan of C. elegans” and negative entries, compounds that “do not increase the lifespan of C. elegans4. In particular, the dataset contains 1392 compounds of which 229 are positive and 1163 are negative entries4. The positive entries of this dataset were obtained from the DrugAge database of ageing-related drugs, (Build 2, release date: 01/09/2016), available on the Human Ageing Genomic Resources website1,69. DrugAge provides information on drugs, compounds and supplements with anti-ageing properties that have been found to extend the lifespan of model organisms1. The species include worms, mice and flies, with the majority of data representing C. elegans4. Data has been obtained from studies performed under standard conditions and contain information relevant to ageing, such as average/median lifespan, maximum lifespan, strain, dosage and gender where available1. The negative entries of the database used in the study of Barardo et al. (2017) were obtained from the literature.

At the time of writing, the latest version of the DrugAge database, Build 3 (release date: 19/07/2019), corrects for small errors and adds hundreds of new entries. Herein, the positive entries in the database used in Barardo et al. (2017) were replaced with the data from the newest version of DrugAge, Build 3. The same negative entries as Barardo et al. (2017) were used4. The modified database contained a total of 1558 compounds with 395 positive entries and 1163 negative ones. In this study, the term “DrugAge database” refers to the modified dataset with a total of 1558 compounds.

Representation of chemical compounds

The chemical structures of the DrugAge dataset were converted into canonical SMILES strings using the Python package PubChemPy70. The SMILES strings were standardised by the Standardiser tool developed by Francis Atkinson in 201471. Standardisation removed inorganic compounds, salt/solvent components and metal species as well as neutralised the compounds by adding or removing hydrogen atoms71. Stereoisomers, even if biologically may have different activities, were treated as duplicates as they had identical SMILES strings. For two or more stereoisomers in the same class, only one was kept. For duplicates in different classes, both were removed72. After standardisation and duplicate removal, the number of molecules in the DrugAge database was reduced to a total of 1430 compounds with 304 positive and 1126 negative entries. The predictive database used in this study can be found in Additional File 2.

Molecular descriptor generation

The standardised SMILES strings were converted into mol files in the RDKit environment and opened in the MOE software19,23. The chemical structures were energy minimised in the Energy Minimize General mode of MOE using Amber10:EHT force field23. A total of 354 descriptors were calculated including all 2D, internal i3D and external x3D coordinate depended on 3D descriptors. Due to software limitation, few 3D descriptors ('AM1_E', 'AM1_Eele', 'AM1_HF', 'AM1_HOMO', 'AM1_IP', 'AM1_LUMO', 'MNDO_E', 'MNDO_Eele', 'MNDO_HF', 'MNDO_HOMO', 'MNDO_IP', 'MNDO_LUMO', 'PM3_E', 'PM3_Eele', 'PM3_HF', 'PM3_HOMO', 'PM3_IP', 'PM3_LUMO') could not be calculated for ten chemical structures. The missing values were replaced with the average value of the remaining chemical structures for the given descriptor.

Molecular fingerprint generation

Molecular fingerprints were generated in the Python RDKit environment from the standardised SMILES strings19. ECFP of 1024-bits and 2048-bits length were calculated with an atomic radius of 2. These were represented as “ECFP_1024” and “ECFP_2048”, respectively. In addition to the ECFPs, RDKit topological fingerprints of 2048-bits length were generated with a maximum path length of 5 bonds and denoted as “RDKit5”.

Five random forest models were built using five different feature types and trained with the data of the DrugAge database. The feature types explored in this study, ECFP_1024, ECFP_2048, RDKit5, MD and ECFP_1024_MD, are summarised in Supplementary Table 1, Additional File 1. The ECFP_1024_MD feature was a combined descriptor type consisting of ECFPs of 1024 bit-length and molecular descriptors.

Feature selection

Feature selection was implemented in the scikit-learn Python library22. Features with low variance were removed first, creating three feature subsets var_100, var_95 and var_90. The filters removed features with the same value in all entries (var_100), features that had greater than 95% of constant values (var_95) and features with more than 90% constant values, respectively (var_90)73.

Mutual Information (MI) is a filter-based feature selection method used to measure the dependency between two variables. The MI between variables \(X\) and \(Y\) is given by (Eq. 3):

$$MI\left( {X;Y} \right) = ~\mathop \sum \limits_{x} \mathop \sum \limits_{y} p\left( {x,y} \right)~log\frac{{p\left( {x,y} \right)}}{{p\left( x \right)p\left( y \right)}}$$
(3)

where \(p\left( {x,y} \right)\) is the joint probability mass function and \(p\left( x \right)\) and \(p\left( y \right)\) are the marginal probability mass functions for \(X\) and \(Y\), respectively74. Herein, Adjusted Mutual Information (AMI) was calculated between each feature and the class labels. AMI was used as it is a variation of MI that adjusts for chance75.

For each of the feature subset, AMI was applied using the “adjusted_mutual_info_score” function of scikit-learn to order the features based on their AMI score22. The following settings were tested: using 5%, 10%, 25%, 50%, 75% and 100% of the features with the highest AMI score73. For example, if var_100 for MD contained 349 features, the database with 5% of the features would consist only of the 17 highest-ranking features. This process is outlined in Supplementary Fig. 2, Additional File 1.

Tenfold cross-validation

Cross-validation was performed in the scikit-learn Python library using the “cross_val_score” function22. The predictive database was randomly split into 80% training and 20% test set. The tenfold cross-validation was performed only on the training set. The performance of the models was evaluated using the AUC measure. Cross-validation was repeated 10 times, yielding 10 AUC scores. The predictive accuracy reported was the median AUC value of the 10 measurements obtained by cross-validation. The median, rather than average, AUC score was calculated as the former is more robust to outliers4.

Random forest settings

The random forest classifiers were built in the scikit-learn Python module22. To handle the unbalanced data used in this study, the random forest parameter “class_weight” was set to “balanced”. The remaining parameters of the random forest classifier were set to their default settings. The models were run with 100 estimators (number of trees in the forest) and the maximum number of features considered in each tree node was the square root of the total number of features. The AUC scores were calculated with the “roc_auc_score” matrix of scikit-learn using the “predict_proba” method22.

Screening database

The best performing model on the test set was applied to predict the class of the compounds in an external database, where the effect of the compounds on the lifespan of C. elegans was mostly unknown. The external database consisted of small-molecules obtained from the External Drug Links database of DrugBank (version 5.1.5, released on 2020-01-03)11. The External Drug Links database contained a list of drugs and links to other databases, such as PubChem and UniProt, providing information on these compounds11,76,77.

Generation of SMILES strings, standardisation and descriptor calculation was performed in the same method used for the training (DrugAge) database, described in the above sections. Some of the entries of the DrugBank database were substances composed of more than one molecule, such as vegetable oils. These entries were either removed from the database or replaced by one of their main active ingredients. For example, “borage oil” was replaced with “gamolenic acid”. In the case of “soy isoflavones”, the major soy isoflavones (genistein, glycitein, and daidzein) had already been experimentally evaluated on the lifespan of C. elegans. Therefore, the entry was replaced with “6''-O-malonyldaidzin”, a derivative of daidzein with unknown activity. Stereoisomers were treated as duplicates and only one of them was kept. Substances and stereoisomers present in both the DrugBank and DrugAge databases were removed from the screening database. The resulting database consisted of a total of 1738 small-molecules.

Tanimoto coefficient and similarity maps

The Tanimoto coefficients and similarity maps were computed in the Python RDKit environment19. The Tanimoto similarity is calculated between a reference molecule, which is known to be active, and a compound of interest with unknown activity.

Herein, the reference molecules were the positive entries of the DrugAge database. The compound with unknown activity was a selected entry from the screening database. The Tanimoto coefficient between the compound of interest with each of the reference molecules was calculated. The highest score achieved and the reference molecule used to obtain that score was reported. The Tanimoto coefficients were computed using the RDKit fingerprint representations of the compounds. Similarity maps were generated using ECFP fingerprint representations.

References

  1. Barardo, D. et al. The DrugAge database of aging-related drugs. Aging Cell 16, 594–597 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  2. Qian, M. & Liu, B. Advances in pharmacological interventions of aging in mice. Transl. Med. Aging 3, 116–120 (2019).

    Article  Google Scholar 

  3. Blagosklonny, M. V. Disease or not, aging is easily treatable. Aging 10, 3067–3078 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  4. Barardo, D. G. et al. Machine learning for predicting lifespan-extending chemical compounds. Aging 9, 1721–1737 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  5. Lee, G. D. et al. Dietary deprivation extends lifespan in Caenorhabditis elegans. Aging Cell 5, 515–524 (2006).

    CAS  PubMed  Article  Google Scholar 

  6. Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392–395 (2009).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  7. Selman, C. et al. Ribosomal protein S6 Kinase 1 Signaling regulates mammalian life span. Science 326, 140–144 (2009).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  8. Ye, X., Linton, J. M., Schork, N. J., Buck, L. B. & Petrascheck, M. A pharmacological network for lifespan extension in Caenorhabditis elegans. Aging Cell 13, 206–215 (2014).

    CAS  PubMed  Article  Google Scholar 

  9. Putin, E. et al. Deep biomarkers of human aging: Application of deep neural networks to biomarker development. Aging 8, 1021–1033 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  10. Mamoshina, P. et al. Population specific biomarkers of human aging: A big data study using South Korean, Canadian, and Eastern European patient populations. J. Gerontol. A. Biol. Sci. Med. Sci. 73, 1482–1490 (2018).

    PubMed  PubMed Central  Article  Google Scholar 

  11. Wishart, D. S. et al. DrugBank 50: A major update to the DrugBank database for 2018. Nucl. Acids Res. 46, D1074–D1082 (2018).

    CAS  PubMed  Article  Google Scholar 

  12. Schlager, S., Zheng, G., Li, S. & Szekely, G. Statistical Shape and Deformation Analysis (Elsevier, 2017). https://doi.org/10.1016/C2015-0-06799-5.

    Book  Google Scholar 

  13. Winter, R., Montanari, F., Noé, F. & Clevert, D.-A. Learning continuous and data-driven molecular descriptors by translating equivalent chemical representations. Chem. Sci. 10, 1692–1701 (2019).

    CAS  PubMed  Article  Google Scholar 

  14. Hong, H. et al. Mold2, molecular descriptors from 2D structures for chemoinformatics and toxicoinformatics. J. Chem. Inf. Model. 48, 1337–1344 (2008).

    CAS  PubMed  Article  Google Scholar 

  15. Gaba, V., Rani, K. & Gupta, M. K. QSAR study on 4-alkynyldihydrocinnamic acid analogs as free fatty acid receptor 1 agonists and antidiabetic agents: Rationales to improve activity. Arab. J. Chem. 12, 1758–1764 (2019).

    Article  CAS  Google Scholar 

  16. Roy, K., Kar, S. & Das, R. N. Chapter 2: Chemical Information and Descriptors. in Understanding the Basics of QSAR for Applications in Pharmaceutical Sciences and Risk Assessment 47–80 (Academic Press, 2015). https://doi.org/10.1016/B978-0-12-801505-6.00002-8.

  17. Lo, Y. C., Rensi, S. E., Torng, W. & Altman, R. B. Machine learning in chemoinformatics and drug discovery. Drug Discov. Today 23, 1538–1546 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  18. Perkins, R., Fang, H., Tong, W. & Welsh, W. J. Quantitative structure-activity relationship methods: Perspectives on drug discovery and toxicology. Environ. Toxicol. Chem. 22, 1666–1679 (2003).

    CAS  PubMed  Article  Google Scholar 

  19. RDKit: Open-source cheminformatics, accessed April 2020; http://www.rdkit.org

  20. Sonego, P., Kocsor, A. & Pongor, S. ROC analysis: Applications to the classification of biological sequences and 3D structures. Brief. Bioinform. 9, 198–209 (2008).

    PubMed  Article  Google Scholar 

  21. Chen, C. & Breiman, L. Using Random Forest to Learn Imbalanced Data (Univ. California, 2004).

    Google Scholar 

  22. Pedregosa, F. et al. Scikit-learn. J. Mach. Learn. Res. 12, 2825–2830 (2011).

    MathSciNet  MATH  Google Scholar 

  23. Chemical Computing Group Inc. Molecular Operating Environment (2019.01) Montreal, Canada. (2019).

  24. Bender, A. & Glen, R. C. A discussion of measures of enrichment in virtual screening: Comparing the information content of descriptors with increasing levels of sophistication. J. Chem. Inf. Model. 45, 1369–1375 (2005).

    CAS  PubMed  Article  Google Scholar 

  25. Gozalbes, R. & Doucet, J. P. Application of topological descriptors in QSAR and drug design: History and new trends. Infect. Disord. Drug Targets 2, 93–102 (2002).

    CAS  Article  Google Scholar 

  26. Guha, R. & Willighagen, E. A survey of quantitative descriptions of molecular structure. Curr. Top. Med. Chem. 12, 1946–1956 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  27. Gasteiger, J. & Marsili, M. Iterative partial equalization of orbital electronegativity—A rapid access to atomic charges. Tetrahedron 36, 3219–3228 (1980).

    CAS  Article  Google Scholar 

  28. Kleinoeder, T. Prediction of Properties of Organic Compounds: Emperical Methods and Management of Property Data. (PhD Thesis, University of Erlangen-Nuernberg., 2005).

  29. Djoumbou Feunang, Y. et al. ClassyFire: Automated chemical classification with a comprehensive, computable taxonomy. J. Cheminform. 8, 61 (2016).

    PubMed  PubMed Central  Article  Google Scholar 

  30. Prasain, J. K., Carlson, S. H. & Wyss, J. M. Flavonoids and age-related disease: Risk, benefits and critical windows. Maturitas 66, 163–171 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  31. Ayaz, M. et al. Flavonoids as prospective neuroprotectants and their therapeutic propensity in aging associated neurological disorders. Front. Aging Neurosci. 11, 155 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  32. Ramelet, A. A. Venoactive drugs. In Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins (eds Goldman, M. P. et al.) 369–377 (W.B. Saunders, 2011). https://doi.org/10.1016/B978-0-323-07367-7.00020-0.

    Chapter  Google Scholar 

  33. Mangoni, A. A. Drugs acting on the cerebral and peripheral circulations. In A Worldwide Yearly Survey of New Data in Adverse Drug Reactions and Interactions Vol. 34 (ed. Aronson, J. K.) 311–316 (Elsevier, 2012).

    Chapter  Google Scholar 

  34. Kamel, R., Abbas, H. & Fayez, A. Diosmin/essential oil combination for dermal photo-protection using a lipoid colloidal carrier. J. Photochem. Photobiol. B Biol. 170, 49–57 (2017).

    CAS  Article  Google Scholar 

  35. Bergan, J. J., Schmid-Schönbein, G. W. & Takase, S. Therapeutic approach to chronic venous insufficiency and its complications: Place of Daflon 500 mg. Angiology 52(Suppl 1), S43–S47 (2001).

    PubMed  Article  Google Scholar 

  36. Ganeshpurkar, A. & Saluja, A. K. The pharmacological potential of rutin. Saudi Pharm. J. 25, 149–164 (2017).

    PubMed  Article  Google Scholar 

  37. Chattopadhyay, D. et al. Hormetic efficacy of rutin to promote longevity in Drosophila melanogaster. Biogerontology 18, 397–411 (2017).

    CAS  PubMed  Article  Google Scholar 

  38. Riniker, S. & Landrum, G. A. Similarity maps: A visualization strategy for molecular fingerprints and machine-learning methods. J. Cheminform. 5, 43 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  39. Xue, Y. L. et al. Isolation and Caenorhabditis elegans lifespan assay of flavonoids from onion. J. Agric. Food Chem. 59, 5927–5934 (2011).

    CAS  PubMed  Article  Google Scholar 

  40. Cordeiro, L. M. et al. Rutin protects Huntington’s disease through the insulin/IGF1 (IIS) signaling pathway and autophagy activity: Study in Caenorhabditis elegans model. Food Chem. Toxicol. 141, 111323 (2020).

    CAS  PubMed  Article  Google Scholar 

  41. Sun, K. et al. Anti-Aging effects of hesperidin on saccharomyces cerevisiae via inhibition of reactive oxygen species and UTH1 gene expression. Biosci. Biotechnol. Biochem. 76, 640–645 (2012).

    CAS  PubMed  Article  Google Scholar 

  42. Fernández-Bedmar, Z. et al. Role of citrus juices and distinctive components in the modulation of degenerative processes: Genotoxicity, antigenotoxicity, cytotoxicity, and longevity in drosophila. J. Toxicol. Environ. Heal. Part A 74, 1052–1066 (2011).

    Article  CAS  Google Scholar 

  43. Wang, J. et al. Effects of orange extracts on longevity, healthspan, and stress resistance in Caenorhabditis elegans. Molecules 25, 1–17 (2020).

    Google Scholar 

  44. Lee, E. B. et al. Genistein from vigna angularis extends lifespan in caenorhabditis elegans. Biomol. Ther. (Seoul) 23, 77–83 (2015).

    CAS  Article  Google Scholar 

  45. Gutierrez-Zepeda, A. et al. Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans. BMC Neurosci. 6, 54 (2005).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  46. Fischer, M. et al. Phytoestrogens genistein and daidzein affect immunity in the nematode Caenorhabditis elegans via alterations of vitellogenin expression. Mol. Nutr. Food Res. 56, 957–965 (2012).

    CAS  PubMed  Article  Google Scholar 

  47. Wishart, D. S. et al. HMDB 4.0: The human metabolome database for 2018. Nucl. Acids Res. 46, D608–D617 (2018).

    CAS  PubMed  Article  Google Scholar 

  48. Papsdorf, K. & Brunet, A. Linking lipid metabolism to chromatin regulation in aging. Trends Cell Biol. 29, 97–116 (2019).

    CAS  PubMed  Article  Google Scholar 

  49. Han, S. et al. Mono-unsaturated fatty acids link H3K4me3 modifiers to C. elegans lifespan. Nature 544, 185–190 (2017).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. Johnson, A. A. & Stolzing, A. The role of lipid metabolism in aging, lifespan regulation, and age-related disease. Aging Cell 18, e13048 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  51. O’Rourke, E. J., Kuballa, P., Xavier, R. & Ruvkun, G. ω-6 Polyunsaturated fatty acids extend life span through the activation of autophagy. Genes Dev. 27, 429–440 (2013).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  52. Shemesh, N., Meshnik, L., Shpigel, N. & Ben-Zvi, A. Dietary-induced signals that activate the gonadal longevity pathway during development regulate a proteostasis switch in caenorhabditis elegans adulthood. Front. Mol. Neurosci. 10, 254 (2017).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  53. Qi, W. et al. The ω-3 fatty acid α-linolenic acid extends Caenorhabditis elegans lifespan via NHR-49/PPARα and oxidation to oxylipins. Aging Cell 16, 1125–1135 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  54. Sugawara, S., Honma, T., Ito, J., Kijima, R. & Tsuduki, T. Fish oil changes the lifespan of Caenorhabditis elegans via lipid peroxidation. J. Clin. Biochem. Nutr. 52, 139–145 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  55. Khan, S. A., Haider, A., Mahmood, W., Roome, T. & Abbas, G. Gamma-linolenic acid ameliorated glycation-induced memory impairment in rats. Pharm. Biol. 55, 1817–1823 (2017).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  56. Knauf, V. C., Shewmaker, C., Flider, F., Emlay, D. & Ray, E. Safflower with Elevated Gamma-Linolenic Acid. US Patent 2011/0129428A1, Jun. 2, 2011. (2011).

  57. Rezapour-Firouzi, S. Chapter 24: Herbal oil supplement with hot-nature diet for multiple sclerosis. In Nutrition and Lifestyle in Neurological Autoimmune Diseases (eds Watson, R. R. & Killgore, W. D. S.) 229–245 (Academic Press, 2017). https://doi.org/10.1016/B978-0-12-805298-3.00024-4.

    Chapter  Google Scholar 

  58. De Giorgio, R. et al. Chronic constipation in the elderly: A primer for the gastroenterologist. BMC Gastroenterol. 15, 130 (2015).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  59. Honda, Y., Tanaka, M. & Honda, S. Trehalose extends longevity in the nematode Caenorhabditis elegans. Aging Cell 9, 558–569 (2010).

    CAS  PubMed  Article  Google Scholar 

  60. Xing, S. et al. Lactose induced redox-dependent senescence and activated Nrf2 pathway. Int. J. Clin. Exp. Pathol. 12, 2034–2045 (2019).

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Yahia, E. M., Carrillo-López, A. & Bello-Perez, L. A. Carbohydrates. In Postharvest Physiology and Biochemistry of Fruits and Vegetables (ed. Yahia, E. M.) 175–205 (Woodhead Publishing, 2019). https://doi.org/10.1016/B978-0-12-813278-4.00009-9.

    Chapter  Google Scholar 

  62. Edwards, C. et al. Mechanisms of amino acid-mediated lifespan extension in Caenorhabditis elegans. BMC Genet. 16, 8 (2015).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  63. Zheng, J. et al. Lower doses of fructose extend lifespan in caenorhabditis elegans. J. Diet. Suppl. 14, 264–277 (2017).

    CAS  PubMed  Article  Google Scholar 

  64. Wang, X. et al. Effects of excess sugars and lipids on the growth and development of Caenorhabditis elegans. Genes Nutr. 15, 1 (2020).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  65. Rovenko, B. M. et al. High sucrose consumption promotes obesity whereas its low consumption induces oxidative stress in Drosophila melanogaster. J. Insect Physiol. 79, 42–54 (2015).

    CAS  PubMed  Article  Google Scholar 

  66. Yang, N. et al. Lactulose enhances neuroplasticity to improve cognitive function in early hepatic encephalopathy. Neural Regen. Res. 10, 1457–1462 (2015).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  67. Munsiff, S. S., Kambili, C. & Ahuja, S. D. Rifapentine for the treatment of pulmonary tuberculosis. Clin. Infect. Dis. 43, 1468–1475 (2006).

    CAS  PubMed  Article  Google Scholar 

  68. Golegaonkar, S. et al. Rifampicin reduces advanced glycation end products and activates DAF-16 to increase lifespan in Caenorhabditis elegans. Aging Cell 14, 463–473 (2015).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  69. Tacutu, R. et al. Human Ageing Genomic Resources: Integrated databases and tools for the biology and genetics of ageing. Nucl. Acids Res. 41, D1027–D1033 (2013).

    CAS  PubMed  Article  Google Scholar 

  70. PubChemPy, accessed April 2020; https://pypi.org/project/PubChemPy/

  71. Atkinson, F. L. Standardiser, accessed April 2020; https://github.com/flatkinson/standardiser. (2014).

  72. Kotsampasakou, E. & Ecker, G. F. Predicting drug-induced cholestasis with the help of hepatic transporters-an in silico modeling approach. J. Chem. Inf. Model. 57, 608–615 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  73. Fehér, N. K. Exploring Predicted Drug Metabolism in in silico Toxicity Prediction. Dissertation, University of Cambridge (2018).

  74. Cover, T. M. & Thomas, J. A. Entropy, relative entropy, and mutual information. in Elements of Information Theory 13–55 (John Wiley & Sons, 2006).

  75. Vinh, N. X., Epps, J. & Bailey, J. Information Theoretic Measures for Clusterings Comparison: Is a Correction for Chance Necessary? in Proceedings of the 26th Annual International Conference on Machine Learning 1073–1080 (Association for Computing Machinery, 2009). https://doi.org/10.1145/1553374.1553511.

  76. Kim, S. et al. PubChem 2019 update: Improved access to chemical data. Nucl. Acids Res. 47, D1102–D1109 (2018).

    PubMed Central  Article  Google Scholar 

  77. Consortium, T. U. UniProt: A worldwide hub of protein knowledge. Nucl. Acids Res. 47, D506–D515 (2018).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to the members of the Department of Chemistry at the University of Surrey for their support throughout the study.

Author information

Authors and Affiliations

Authors

Contributions

S.K. and B.H. wrote the main manuscript text . All authors reviewed the manuscript.

Corresponding author

Correspondence to Brendan J. Howlin.

Ethics declarations

Competing interests

The authors declare no competing interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kapsiani, S., Howlin, B.J. Random forest classification for predicting lifespan-extending chemical compounds. Sci Rep 11, 13812 (2021). https://doi.org/10.1038/s41598-021-93070-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41598-021-93070-6

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing